development and commercial milestones taking the potential value of the alliance to a maximum of $594 million. In both cases, the AI specialists will deliver small-molecule drugs to Merck for ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...

Merck Korea Managing Director Kim Woo-kyu, left and Merck Electronics Chief Commercial Officer Anand Nambiar pose for a photo at Semicon Korea 2025. [MERCK KOREA] Merck Electronics Chief ...

Merck's German-listed shares closed down 3.7%. Stamford, Connecticut-based SpringWorks, which listed its shares in New York in 2019, is a commercial-stage biotech firm that develops drugs to treat ...

Merck Germany also confirmed that no legally ... SpringWorks Therapeutics’ first commercial product, Ogsiveo (nirogacestat), is a twice-daily oral medication that is the first and only FDA ...

Merck, in a statement ... which listed its shares in New York in 2019, is a commercial-stage biotech firm that develops drugs to treat various forms of cancer, including rare tumors and uterine ...